|MDACC Study No:||2005-0524 (clinicaltrials.gov NCT No: NCT00210665)|
|Title:||A Multicenter Open-Label Single-Arm Study of YONDELIS® (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment|
|Principal Investigator:||Shreyaskumar R. Patel|
|Treatment Agent:||Dexamethasone; ET-743|
|Study Description:||The goal of this clinical research study is to give previously treated patients |
with soft tissue sarcoma access to the experimental drug trabectedin (ET-743,
YONDELIS) before it becomes commercially available. The safety of trabectedin
will also be studied.